AstraZeneca's blockbuster breast cancer drug will be added to China's national reimbursement scheme list, according to an ...

AstraZeneca's Fasenra, an injectable treatment for severe asthma, is more effective during attacks than the oral steroid that ...

AstraZeneca's blockbuster breast cancer drug will be added to China's national reimbursement scheme list, according to an ...

AstraZeneca's (NASDAQ:AZN) blockbuster cancer medication, Enhertu, developed with Japanese pharma giant Daiichi Sankyo (OTCPK ...

AstraZeneca (AZN) reported positive results from a Phase 3 study of its drug Truqap in the treatment of a certain type of ...

AstraZeneca PLC AZN shares were unchanged Monday at £104.74, on what proved to be an all-around great trading session for the ...

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In this article, we are going to ...

AstraZeneca Pharmaceuticals LP violated federal and Ohio law when it denied a Christian sales specialist an exemption from ...

The market seemed underwhelmed by last week's earnings announcement from AstraZeneca PLC ( LON:AZN) despite the healthy ...

Dr. Bob Li, a top Asian leader from the New York-based Memorial Sloan Kettering Cancer Center, has become global head of ...

Analyst Andrew Berens from Leerink Partners maintained a Buy rating on AstraZeneca (AZN – Research Report) and keeping the price target at ...

The failure of the trial of the drug AZD4041 by pharma giant AstraZeneca, to combat opioid use disorder (OUD), highlights the ...